HocerMed Gets Over 100 Million Yuan in Series C Round

HocerMed, a provider of minimally invasive surgery solutions, announced the completion of a Series C financing of over 100 million yuan. This round of financing was led by Hillhouse Ventures, followed by Gaoke Xinjun, and Haoyue Capital served as the exclusive financial advisor.

This round of financing will help HocerMed accelerate the development and application transformation process in the field of minimally invasive surgery, promote the company's sales channel construction and overseas marketing network construction, and further expand production capacity.

With the gradual penetration of minimally invasive surgery in China, the market demand for minimally invasive surgical instruments is increasing. The prospectus of a number of listed companies shows that the domestic minimally invasive surgical instrument market in 2019 has exceeded 18 billion yuan in 5 years. It is expected to reach 40 billion yuan later. However, due to high technical barriers, patent blockade and other reasons, overseas giants represented by Johnson & Johnson and Medtronic account for more than 80% of the market share in this field all year round.

According to Wang Lin, partner of Hi-Tech Xinjun, the minimally invasive surgical ultrasonic scalpel market is ushering in two major changes, one is from repeated use to one-time use, and the other is domestic substitution, which will bring about rapid growth in market capacity and market competition. For the reshaping of the pattern, leading domestic companies need to cherish this window of opportunity.

Since its establishment, HocerMed has gone through the stages of technology accumulation and clinical transformation, and now has an ultrasonic cutting hemostatic knife system, including two generations of ultrasonic host products, USE, USS, MIC and other series of ultrasonic blades for different departments and indications.

HocerMed said that the quality and technology of their products have been verified by hundreds of large hospitals in China and have served hundreds of hospitals around the world, including Europe and North America.

HocerMed will continue to deepen the field of minimally invasive surgery and build barriers in this field. At present, HocerMed has provided supporting energy surgical instruments and integrated surgical energy platform products to domestic and foreign surgical robot manufacturers, and has entered the field of surgical robots, reflecting its determination to continue to build high barriers in the field of minimally invasive surgery.